| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 366 |
| 1 | METHOTREXATE SODIUM | 361 |
| 2 | METHOTREXATE | 343 |
| 3 | PREDNISONE | 333 |
| 4 | MYCOPHENOLATE MOFETIL | 266 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 266 |
| 6 | CYCLOPHOSPHAMIDE | 261 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 261 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 261 |
| 9 | DOXORUBICIN | 194 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROQUINE PHOSPHATE | 12 | 0.0182 |
| 1 | THIOTEPA | 38 | 0.0039 |
| 2 | CHLORAMBUCIL | 13 | 0.0033 |
| 3 | VINCRISTINE SULFATE | 97 | 0.0033 |
| 4 | DOXORUBICIN HYDROCHLORIDE | 90 | 0.0027 |
| 5 | BELATACEPT | 11 | 0.0023 |
| 6 | CYTARABINE | 136 | 0.0022 |
| 7 | DOXORUBICIN | 194 | 0.0021 |
| 8 | TEMOZOLOMIDE | 43 | 0.0020 |
| 9 | RITUXIMAB-ABBS | 10 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 573 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 384 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 346 |
| 3 | Alkylating Drug [EPC] | 325 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 140 |
| 5 | Kinase Inhibitor [EPC] | 127 |
| 6 | Topoisomerase Inhibitor [EPC] | 81 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 81 |
| 8 | Thalidomide Analog [EPC] | 79 |
| 9 | Purine Antimetabolite [EPC] | 75 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 11 | 0.0023 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 41 | 0.0019 |
| 4 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 32 | 0.0017 |
| 6 | Alkylating Drug [EPC] | 325 | 0.0013 |
| 7 | Sulfonamide Antibacterial [EPC] | 5 | 0.0013 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 384 | 0.0012 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 18 | 0.0011 |